Tiedemann Advisors’s Celgene Corp CELG Stock Holding History

Tiedemann Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,672	Closed	-$725K	–	454
2019 Q1	$725K	Buy	7,672 +35	+0.5%	+$3.06K	0.03%	258
2018 Q4	$490K	Sell	7,637 -1,123	-13%	-$82.9K	0.03%	288
2018 Q3	$785K	Hold	8,760	–	–	0.05%	191
2018 Q2	$696K	Buy	8,760 +208	+2%	+$17.3K	0.04%	200
2018 Q1	$764K	Buy	+8,552	New	+$821K	0.05%	164
2017 Q4	–	Sell	-1,725	Closed	-$251K	–	392
2017 Q3	$251K	Sell	1,725 -17,387	-91%	-$2.37M	0.02%	301
2017 Q2	$2.48M	Buy	19,112 +8,893	+87%	+$1.09M	0.18%	106
2017 Q1	$1.27M	Buy	10,219 +1,612	+19%	+$193K	0.11%	156
2016 Q4	$996K	Sell	8,607 -850	-9%	-$94.7K	0.1%	150
2016 Q3	$929K	Buy	+9,457	New	+$1.02M	0.19%	64

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Tiedemann Advisors's CELG Position: Q2 2019 in Review

Tiedemann Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 7,672 shares — an estimated $725K sold.

Tiedemann Advisors first reported a position in CELG in Q3 2016 and held it in 10 quarters. The position peaked at $2.48M in Q2 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Tiedemann Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Tiedemann Advisors sold 7,672 Celgene Corp shares in Q2 2019, an estimated $725K.
Tiedemann Advisors first reported a position in Celgene Corp in Q3 2016 and held it in 10 quarters.
Tiedemann Advisors's Celgene Corp position peaked at $2.48M in Q2 2017.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Tiedemann Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.